
The renin–angiotensin system (RAS) regulates blood pressure and cardio-renal function. While the classical RAS, involving angiotensin I and II, is altered in critically ill patients, recent research highlights the alternative RAS. Components like ACE2 and angiotensin-(1–7) play a role, along with peptidases such as dipeptidyl-peptidase 3. In conditions like shock, dipeptidyl-peptidase 3 is linked to acute kidney injury and mortality. Angiotensin-(1–7) prevents septic shock, and ACE2 protects against acute lung injury. Active recombinant human ACE2 and angiotensin-(1–7) have been tested in preclinical and human studies, suggesting that alternative RAS modulation could enhance outcomes in critical illness.
Like
Save
Share